Biomedicines · Nov 17, 2026
Comparative Effects of Atorvastatin and Pravastatin on Endothelial Viability and DRP1-Associated Signaling Following Irradiation
By Mosleh MM, Kim H, Lee M et al.
Background/Objectives: Radiation-induced vasculopathy (RIV) is a delayed complication of radiotherapy characterized by endothelial dysfunction and mitochondrial injury. The effects of statins on radiation-induced mitochondrial stress signaling remain unclear. This study compared atorvastatin and pravastatin for their effects on endothelial viability and DRP1-associated signaling markers after irradiation. Methods: Murine endothelial cells (2H-11) were exposed to ionizing radiation (0–12 Gy). Cells were pretreated for 1 or 18 h with lipophilic atorvastatin (0.01–3 μM) or hydrophilic pravastatin (5–50 μM), with concentration ranges varying according to the experimental phase. Total DRP1, phosphorylated DRP1 (Ser616 and Ser637), FIS1, TFAM, and cleaved caspase-3 were examined by Western blotting without quantification; the 4 h blot was derived from a single independent experiment. Results: Irradiation reduced viability in dose- and time-dependent manners. Atorvastatin reduced viability in a concentration-dependent manner, whereas pravastatin had comparatively limited effects within the tested range, although the two drugs were tested at different concentration ranges. Western blot band patterns varied with irradiation and treatment conditions, but these qualitative observations could not be quantified or statistically analyzed. Conclusions: Atorvastatin and pravastatin differed in their effects on WST-8-derived viability after irradiation. The Western blot observations are exploratory and hypothesis-generating and do not establish changes in DRP1 signaling, mitochondrial dynamics, or protection; independent validation is required.
doi.org/10.3390/biomedicines14112657Open accessInterventions